Strong support Asefarma to our pharmaceutical model following the measures announced in Italy.

Currently the ratio in which the Spanish pharmacy moves is an apothecary for every 2,000 inhabitants. A ratio that ensures that 99% of the population of our country (out of a total of 47 million people) have access to health care professionals.

Spanish pharmaceutical model sits on these bases. A model that today find supporters and detractors in the same proportion, especially since the launch in Italy of the liberalizing measures announced by the Prime Minister and Minister of economy and finance Italian, Mario Monti, and which has opened the debate on whether it is feasible to this liberalisation in Spain.

The transalpine country has begun the year with a new package of measures to implement solution to what are considered ballast of the country’s economy: insufficient market competition and the inadequacy of Italian infrastructure. Such measures would affect sectors professional such as taxi, fuels or pharmacies.

The latter would be affected by the freedom of schedules, increased competition and the reduction in the price of medicines (even those prescription drugs not funded, could be sold outside pharmacies). In the words of the Italian Prime Minister increased competition will be a fall in prices which will benefit citizens hand ”.

Addition, the Italian Government has recently announced the opening of 5,000 pharmacies, which would reduce the Italian ratio in a pharmacy for every 3,000 inhabitants, rather than one for every 3,400, as had been her up takes effect of these measures against the crisis.

In short, what ensures with these new openings, it is that health care provided by the pharmacist, in a manner closer to the population. something that we already have with the pharmaceutical model of our country, with lower population density, ensuring that 99% of Spaniards have access to a pharmacy in any corner of the país, by far to be of large urban or population nuclei.

According to Carlos García-Mauriñoy, President, Asefarma Ejecutivo, we hope and pray that the Spanish pharmaceutical model, argued before the European Commission by the current Minister at the time of MEP (2004-2008), maintain and continue the same accessibility to drugs with which we have had so far continue working from the Ministry of health, ”.

I.e., to this day, is not change models or to do a review of the number of boticas in our country. It’s value that the number of pharmacies in Spain currently guarantees access to a health professional of 99% of the population. Therefore, the key lies in refine and boost that professional service to the client/patient ”, explains the Executive Chairman of Asefarma.

In Asefarma, we are convinced that this will be. Maintain our conviction the need that innovation, competitiveness and specialization are incorporated into the Decalogue of the Spanish pharmacy performance, because only this will thus be able to cope with the crisis situation facing all sectors of the economy.

What is ASEFARMA:

It is advised by dynamic management of the pharmacy of reference and whose services are given to more than 300 boticas in throughout the Spanish geography. Its main asset is human capital, and has 43 high-level professionals in the pharmaceutical sector, economists, lawyers and pharmacists at your service. Publishes a quarterly newsletter that receive more than 10,000 pharmacies in all Spain and is market leader in the sales of pharmacies, providing a clear added value in that area regarding its competence. It has excellent Madrid certification and quality issued by EQA, ISO 9001 certification.

ASEFARMA, award for the best Blog for pharmacists awarded by medical journal, email pharmacist specialized publications: elblogdeasefarma.blogspot.com